6.80
price down icon3.68%   -0.26
after-market Dopo l'orario di chiusura: 6.80
loading

Diamedica Therapeutics Inc Azioni (DMAC) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Research and Development
2.93%
5.822
5.656 6.47 4.983 3.928
Operating Income/Loss
1.68%
-8.007
-8.144 -8.419 -6.883 -5.638
Nonoperating Income/Loss
29.12%
0.314
0.443 - - -
Income/Loss From Continuing Operations Before Tax
0.10%
-7.693
-7.701 -7.891 -6.267 -5.112
Income Tax Expense/Benefit
0.00%
0.006
0.006 0.009 0.007 0.007
Income/Loss From Continuing Operations After Tax
0.10%
-7.699
-7.707 -7.90 -6.274 -5.119
Net Income/Loss
0.10%
-7.699
-7.707 -7.90 -6.274 -5.119
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.27%
42.96
42.84 0.8005 42.75 38.07
Basic Earnings Per Share
0.00%
-0.18
-0.18 -0.18 -0.15 -0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Capitalizzazione:     |  Volume (24 ore):